tiprankstipranks
DCM Shriram Limited (IN:DCMSHRIRAM)
:DCMSHRIRAM
India Market

DCM Shriram Limited (DCMSHRIRAM) AI Stock Analysis

0 Followers

Top Page

IN:DCMSHRIRAM

DCM Shriram Limited

(DCMSHRIRAM)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
₹1,209.00
▼(-1.74% Downside)
Action:ReiteratedDate:11/22/25
DCM Shriram Limited shows strong financial performance with robust revenue growth and efficient operations. However, technical indicators suggest a neutral to slightly bearish trend, and the valuation indicates moderate pricing with a low dividend yield. The absence of earnings call and corporate events data limits further insights.
Positive Factors
Diversified manufacturing portfolio
A diversified portfolio across chemicals, sugar and farm solutions reduces single‑market exposure and smooths earnings across commodity cycles. This structural mix supports more stable revenues and long‑term resilience versus single‑segment peers, aiding planning and capex allocation.
Negative Factors
Moderate net profit margin
A modest net margin limits the company’s buffer against input cost spikes or pricing pressure in cyclic businesses like chemicals and sugar. Over time this constrains retained earnings, reduces ability to expand margin through scale, and heightens sensitivity to adverse commodity moves.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified manufacturing portfolio
A diversified portfolio across chemicals, sugar and farm solutions reduces single‑market exposure and smooths earnings across commodity cycles. This structural mix supports more stable revenues and long‑term resilience versus single‑segment peers, aiding planning and capex allocation.
Read all positive factors

DCM Shriram Limited (DCMSHRIRAM) vs. iShares MSCI India ETF (INDA)

DCM Shriram Limited Business Overview & Revenue Model

Company Description
DCM Shriram Limited, together with its subsidiaries, engages in chloro-vinyl, sugar, agri-input, and other businesses in India and internationally. The company operates through Fertilisers, Chloro-Vinyl, Shriram Farm Solutions, Sugar, Bioseed, and...
How the Company Makes Money
DCM Shriram primarily makes money by manufacturing and selling products across its business segments. (1) Chemicals: It earns revenue from sales of chlor-alkali and related chemical products to industrial customers; profitability in this segment i...

DCM Shriram Limited Financial Statement Overview

Summary
DCM Shriram Limited exhibits robust growth in revenue and efficient operations, as reflected in stable margins and effective cost management. The balance sheet is strong with low leverage and good equity ratios, though rising debt levels warrant caution. Cash flow generation is improving, but sustaining free cash flow remains a challenge. Overall, the financial health is solid with areas for potential enhancement in profitability and cash flow stability.
Income Statement
78
Positive
Balance Sheet
72
Positive
Cash Flow
65
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue127.77B120.77B109.22B115.47B96.27B83.08B
Gross Profit38.90B39.27B32.72B36.70B35.54B27.97B
EBITDA15.61B13.26B9.63B15.84B17.63B11.15B
Net Income7.12B6.04B4.47B9.11B10.67B6.73B
Balance Sheet
Total Assets132.21B127.32B115.49B107.22B93.71B77.91B
Cash, Cash Equivalents and Short-Term Investments13.13B9.86B6.59B9.10B15.12B13.16B
Total Debt21.77B25.29B21.52B17.07B15.77B15.21B
Total Liabilities59.76B57.28B50.27B45.28B38.69B31.43B
Stockholders Equity72.25B70.04B65.22B61.94B55.02B46.48B
Cash Flow
Free Cash Flow11.72B2.83B-5.16B-5.07B4.50B16.33B
Operating Cash Flow15.24B11.28B7.94B12.96B12.24B18.87B
Investing Cash Flow-4.70B-8.50B-10.70B-15.43B-9.04B-6.42B
Financing Cash Flow-8.42B-13.90M1.69B-2.35B-2.59B-9.18B

DCM Shriram Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1230.40
Price Trends
50DMA
1092.51
Positive
100DMA
1154.07
Negative
200DMA
1209.83
Negative
Market Momentum
MACD
17.81
Negative
RSI
62.62
Neutral
STOCH
82.25
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DCMSHRIRAM, the sentiment is Positive. The current price of 1230.4 is above the 20-day moving average (MA) of 1064.76, above the 50-day MA of 1092.51, and above the 200-day MA of 1209.83, indicating a neutral trend. The MACD of 17.81 indicates Negative momentum. The RSI at 62.62 is Neutral, neither overbought nor oversold. The STOCH value of 82.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DCMSHRIRAM.

DCM Shriram Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹135.33B48.693.04%-3.03%357.65%
69
Neutral
₹133.28B40.850.48%8.96%17.70%
68
Neutral
₹236.81B31.760.12%-2.24%31.43%
66
Neutral
₹174.64B23.031.01%13.39%36.62%
64
Neutral
₹187.88B28.120.41%16.46%43.59%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
₹154.78B40.150.51%0.43%-42.29%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DCMSHRIRAM
DCM Shriram Limited
1,119.90
113.32
11.26%
IN:AKZOINDIA
Akzo Nobel India Limited
2,971.70
-197.09
-6.22%
IN:ATUL
Atul Limited
6,381.35
1,218.40
23.60%
IN:BASF
BASF India Limited
3,575.80
-793.84
-18.17%
IN:HSCL
Himadri Speciality Chemical Ltd.
469.35
61.87
15.18%
IN:VINATIORGA
Vinati Organics Limited
1,285.70
-156.03
-10.82%

DCM Shriram Limited Corporate Events

DCM Shriram Sets Q3 FY26 Earnings Call for January 23
Jan 15, 2026
DCM Shriram Limited has scheduled its Q3 FY26 earnings conference call for analysts and investors on Friday, January 23, 2026, at 4:00 p.m. IST, following the announcement of its financial results for the quarter ended December 31, 2025. The call ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 22, 2025